Home Tags Pfizer

Tag: Pfizer

Array BioPharma spikes more than 50% after Pfizer shells out $11 billion for the cancer-drug developer

Pfizer's blockbuster deal for Array BioPharma is the latest in a growing list of M&A deals to take place in the cancer-treatment space this year.

EpiPens weren’t working. It took 3 years and the FDA stepping in before serious change — with potentially deadly outcomes

Consumer complaints about EpiPens were increasing, but its manufacturer wasn’t properly looking into those complaints, FDA inspectors warned in 2014.
Pfizer has a new strategy for neuroscience research.

Drug giant Pfizer isn’t ready to abandon neuroscience — here’s its $150-million ‘star cluster’ strategy for betting on p...

Execs from pharma giant Pfizer shared their strategy for keeping an eye on neuroscience — if not from the front row, then at least from the sidelines.
Pharmaceutical companies still have increases planned for January of next year, in spite of President Donald Trump recently shaming Pfizer and others for price hikes.

Trump may have shamed Pfizer for increasing drug prices, but that isn’t stopping drugmakers from doing more of the same

Pharmaceutical companies are increasing drug price again this month, and they could be even larger than usual.
The pain reliever Advil is one of the well-known brands that Pfizer is spinning off as part of a new collaboration with fellow drugmaker GlaxoSmithKline.

Two huge drugmakers are spinning off iconic brands like Advil, ChapStick and Emergen-C with nearly $13 billion in sales — and it’s part of...

The products involved in the deal are familiar pharmacy names, but they also have lower margins than other medicines.

Opioid overdose deaths are highest in places where pharma spends the most on marketing, a new study finds

Researchers at the University of Pittsburgh launched a study to figure out if there's a link between the money that drugmakers spend on opioid marketing and drug-related deaths.
Pfizer incoming CEO Albert Bourla

Pfizer’s CEO is stepping down after 8 years — meet the man who will be replacing him

Pfizer CEO Ian Read is stepping down at the end of 2018, ending his eight-year tenure at the head of the pharma giant. He'll be replaced by Pfizer chief operating officer Albert Bourla in January 2019.

Pfizer’s long-serving CEO, Ian Read, is standing down and being replaced by his chief operating officer

Read, who has been at the helm of the firm since 2010, will stand down on January 1, the company announced Monday. He will be replaced by Pfizer's chief operating officer, Albert Bourla.

Pfizer is holding off on price increases to some of its drugs after being singled out by Trump

After a conversation between President Donald Trump and Pfizer CEO Ian Read, Pfizer said it plans to defer the price increases, returning the prices to where they were before July 1 "as soon as technically possible," the company said in a statement.